Vyera Pharmaceuticals
Stage
DivestitureTotal Raised
$90MInvestors Count
1Deal Terms
1Portfolio Exits
1Funding, Valuation & Revenue
2 Fundings
Vyera Pharmaceuticals has raised $90M over 2 rounds.
Vyera Pharmaceuticals's latest funding round was a Bankrupt/Admin for on May 10, 2023.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
---|---|---|---|---|---|---|
5/10/2023 | Bankrupt/Admin | 1 | ||||
8/7/2015 | Series A |
Date | 5/10/2023 | 8/7/2015 |
---|---|---|
Round | Bankrupt/Admin | Series A |
Amount | ||
Investors | ||
Valuation | ||
Revenue | ||
Sources | 1 |
Vyera Pharmaceuticals Deal Terms
1 Deal Term
Vyera Pharmaceuticals's deal structure is available for 1 funding round, including their Series A from August 07, 2015.
Round | Series A |
---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A |
Vyera Pharmaceuticals Investors
1 Investors
Vyera Pharmaceuticals has 1 investors. Martin Shkreli invested in Vyera Pharmaceuticals's Series A funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
---|---|---|---|---|---|---|
8/7/2015 | 8/7/2015 | 1 Series A | Angel Investor (Individual) |
First funding | 8/7/2015 |
---|---|
Last Funding | 8/7/2015 |
Investor | |
Rounds | 1 Series A |
Board Seats | |
Type | Angel Investor (Individual) |
Location |
Vyera Pharmaceuticals Portfolio Exits
1 Portfolio Exit
Vyera Pharmaceuticals has 1 portfolio exit. Their latest portfolio exit was Turing Pharmaceuticals - Ketamine Program on May 04, 2016.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
5/4/2016 | Divestiture | Turing Pharmaceuticals - Ketamine Program | 1 |
Date | 5/4/2016 |
---|---|
Exit | Divestiture |
Companies | Turing Pharmaceuticals - Ketamine Program |
Valuation | |
Acquirer | |
Sources | 1 |
Loading...